Lidocaine is a drug that combines both local anesthesia and anti-arrhythmic effects. As a derivative of cocaine, it eliminates the hallucinogenic and addictive components present in cocaine while retaining its effective anesthetic and anti-arrhythmic properties. Its hydrochloride form is a white crystalline powder with extremely low solubility in water, but it has good surface penetration ability and can achieve anesthetic effects through injection or surface application.
In clinical applications, lidocaine is regarded as one of the core drugs in the field of local anesthesia due to its rapid onset, long-lasting effect and high safety. At the same time, it is also the preferred drug for treating acute myocardial infarction and cardiac diseases accompanied by ventricular arrhythmias. Particularly, it shows remarkable efficacy in controlling premature ventricular contractions, ventricular tachycardia and ventricular fibrillation.
|
|
|
|
|
|
|
|
Mechanism of Action
Local Anesthesia Mechanism
Lidocaine inhibits the conduction of nerve impulses by blocking sodium ion channels on the cell membrane of nerve cells. When the drug binds to the channel, it alters the conformation of the channel protein and hinders the influx of sodium ions. In normal nerve conduction, the depolarization of the cell membrane depends on the large influx of sodium ions to generate an action potential. The intervention of lidocaine directly interrupts this process, preventing the generation and transmission of nerve impulses. This blocking effect is particularly evident in sensory nerve fibers. For example, in local anesthesia, it can block the sensory conduction of peripheral nerve endings, preventing pain signals and other signals from being transmitted to the central nervous system, thereby achieving a local pain-free effect.
Anti-arrhythmic Mechanism
The inhibitory effect of lidocaine on sodium ion channels in cardiac muscle cells is the core mechanism of its anti-arrhythmic action. By reducing the automaticity of the heart muscle, decreasing the release of abnormal impulses, and simultaneously slowing down the conduction velocity, it blocks the formation of reentrant excitation, thereby correcting arrhythmias. Specifically, it is manifested as:
Reduce self-discipline: Promote the outward flow of potassium ions within myocardial cells, inhibit the inward flow of sodium ions, stabilize the membrane potential of cells, and reduce abnormal electrical activities.
Extend effective refractory period: Make myocardial cells require a longer time to regain excitability after an action potential, preventing rapid arrhythmias caused by consecutive impulses.
Block reentrant excitation： In ischemic or damaged areas of the myocardium, lidocaine can narrow the refractory period difference between normal and ischemic myocardium, eliminate the reentrant loop, and terminate arrhythmias.
Clinical Applications
Local Anesthesia Applications
Surface Anesthesia
Applicable Scenarios： Small surgeries on the skin and mucous membranes (such as wound suturing, tooth extraction), endoscopy (gastroscopy, laryngoscopy), catheterization, tracheal intubation, etc.
Formulation Selection： Gel, spray, or patch. For example, 4% lidocaine solution is used for surface anesthesia of the oral cavity and trachea in adults, and 2% solution is used for children, with an onset time of about 5 minutes and a duration of 15-30 minutes.
Advantages： Simple operation, high patient acceptance, especially suitable for scenarios where patients are sensitive to pain or require rapid anesthesia.
Local Infiltration Anesthesia
Applicable Scenarios： Small surgeries on the skin and subcutaneous tissue (such as tumor resection, abscess drainage).
Concentration and Dose： Commonly used 0.5%-1% solution, with an onset time of 60-120 minutes (the addition of epinephrine affects the onset time).
Operation Points： Layer-by-layer infiltration injection to ensure uniform distribution of the drug, avoiding excessive local concentration that leads to toxic reactions.
Nerve Block Anesthesia
Applicable Scenarios： Limb surgeries (such as arm and leg surgeries), labor analgesia.
Concentration and Dose： 1%-1.5% solution, onset time 10-20 minutes, duration 120-240 minutes. For adults, the single dose is approximately 400mg, and the dose can reach 500mg when epinephrine is added.
Advantages： Precise anesthetic effect, minimal systemic impact, fast postoperative recovery.
Spinal Anesthesia
Applicable Scenarios： Lower abdominal surgeries (such as cesarean section), lower limb surgeries, chronic pain treatment (such as post-herpetic neuralgia).
Concentration and Dose： 1%-2% solution, onset time about 5 minutes, duration 90-120 minutes.
Precautions： Strictly control indications, avoid the drug entering the subarachnoid space and causing total spinal anesthesia, and monitor vital signs during the operation.
Anti-arrhythmic Application
Indications
Ventricular arrhythmias： Acute myocardial infarction, cardiac surgery, digoxin poisoning, etc., causing ventricular premature beats, ventricular tachycardia, ventricular fibrillation.
Emergency Treatment： Used in cardiopulmonary resuscitation to control ventricular arrhythmias and prevent recurrence.
Drug Regimen
Intravenous Injection： Initial loading dose 1-1.5mg/kg (75-100mg), intravenous injection 2-3 minutes, additional 0.5-0.75mg/kg (25-50mg) every 5-10 minutes as necessary, total dose not exceeding 3mg/kg.
Intravenous Infusion： Maintain at a rate of 1-4mg/min, reduce to 1-2mg/min after 24 hours.
Target Blood Drug Concentration： Therapeutic concentration 1.5-5μg/mL, toxic concentration >5μg/mL, convulsive concentration >7μg/mL.
Efficacy Characteristics
Quick Effect： Takes effect within 15-30 seconds after intravenous injection, lasts for about 20 minutes; reaches steady-state concentration 60-75 minutes after intravenous infusion.
Selective Effect： Mainly inhibits the automaticity of ventricular muscle and Purkinje fibers, has a certain inhibitory effect on the conduction of atrioventricular bypass, but has limited effect on supraventricular arrhythmias.
Adverse Reactions and Precautions
Adverse Reactions
Allergic Reaction
Symptoms： Skin itching, rash, urticaria, severe cases may present with breathing difficulties, drop in blood pressure, even anaphylactic shock.
Treatment： Immediately stop the drug, administer anti-allergic treatment (such as epinephrine, glucocorticoids).
Local Tissue Injury
Symptoms： Inappropriate injection leads to vascular injury, tissue necrosis or infection.
Prevention： Strict aseptic operation, avoid the drug entering the blood vessels.
Central nervous system toxicity
Symptoms: dizziness, tinnitus, visual impairment, convulsions, loss of consciousness.
Risk factors: excessively high blood drug concentration (> 5 μg/mL), elderly individuals, those with liver dysfunction.
Treatment: Discontinue the medication, provide oxygen inhalation and sedative drugs, and if necessary, perform life support.
Cardiovascular system reactions
Symptoms: hypotension, bradycardia, atrioventricular conduction block, cardiac arrest.
Risk factors: excessive dosage, combined use of beta-blockers or calcium channel blockers.
Treatment: Adjust the dosage, monitor the electrocardiogram, and if necessary, use vasopressors or a pacemaker.
Precautions
Contraindications
Those allergic to lidocaine or other amide local anesthetics.
Severe atrioventricular conduction block (such as second-degree or above), sick sinus syndrome.
Severe cardiac insufficiency, shock patients (careful assessment is required when using anti-arrhythmic drugs).
Special population medication
Pregnant and lactating women: Use after weighing the pros and cons, and recommend suspending breastfeeding during the medication period for lactating women.
The elderly: Metabolism slows down, reduced dosage should be used, and adverse reactions should be closely monitored.
Those with liver dysfunction: Drug metabolism is delayed, prone to accumulation and poisoning, dosage adjustment is required.
Children: Calculate the dosage based on body weight, avoid excessive dosage.
Drug interactions
Beta-blockers: Combined use may enhance cardiac inhibitory effect, leading to bradycardia or conduction block.
Quinidine, procainamide: May increase the risk of adverse reactions in the nervous and mental system.
Cimetidine: Inhibits lidocaine metabolism, raises blood drug concentration, dosage adjustment is required.
Drug Formulations and Administration Methods
Lorem ipsum dolor sit amet consectetur adipisicing elit.
Injection
Uses: local anesthesia, nerve block, epidural anesthesia, anti-arrhythmic.
Specifications: 0.1g/5mL, 0.2g/10mL, 0.4g/20mL. Usage method:
Local infiltration: 0.5%-1% solution, injected layer by layer.
Nerve block: 1%-1.5% solution, injected around the nerve trunk.
Epidural anesthesia: 1%-2% solution, injected through the epidural catheter.
Anti-arrhythmic: Intravenous injection or drip, the dosage and speed need to be strictly controlled.
Topical preparations
Gel/ointment:
Usage: Surface anesthesia of the skin (such as puncture, superficial surgery), mucosal anesthesia (such as oral, reproductive tract).
Usage method: Apply thickly to the target area, take effect after 30-60 minutes.
Spray:
Usage: Surface anesthesia of the throat, trachea (such as during endoscopy).
Usage method: Spray onto the mucosal surface, take effect within 5 minutes.
Patch:
Usage: Chronic pain (such as post-herpetic neuralgia), postoperative analgesia.
Usage method: Adhere to the pain area, continuously release the drug.
Summary and Outlook
With its dual pharmacological effects, lidocaine occupies an irreplaceable position in clinical anesthesia and arrhythmia treatment. Its rapid onset and long-lasting effect make it the preferred drug for local anesthesia, and its precise intervention in ventricular arrhythmias has saved the lives of countless patients with acute myocardial infarction. However, the safety of the drug needs to be achieved by strictly controlling indications, standardizing operation procedures, and closely monitoring. In the future, with further research on the mechanism of lidocaine's action, its application scope may be further expanded, such as exploration in neurogenic pain, tumor pain, etc., which will provide more treatment options for patients. At the same time, the development of new formulations (such as sustained-release preparations, targeted preparations) is expected to improve drug efficacy and reduce adverse reaction risks, promoting the wider application of lidocaine in clinical practice